| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| IBIO | iBio, Inc. | David Arkowitz | Director | Jan 10, 2025 | Buy | $2.72 | 18,382 | 49,999 | 18,382 | Jan 13, 2025, 04:32 PM | |
| MCRB | Seres Therapeutics, Inc. | David Arkowitz | Chief Financial Officer | Feb 16, 2024 | Sale | $1.08 | 3,939 | 4,254 | 182,442 | Feb 16, 2024, 09:13 PM | |
| MCRB | Seres Therapeutics, Inc. | David Arkowitz | Chief Financial Officer | Feb 15, 2024 | Option/RSU Exercise | - | 10,625 | - | 186,381 | Feb 16, 2024, 09:13 PM | |
| MCRB | Seres Therapeutics, Inc. | David Arkowitz | Chief Financial Officer | Oct 27, 2023 | Option/RSU Exercise | - | 13,209 | - | 179,822 | Oct 31, 2023, 09:39 PM | |
| MCRB | Seres Therapeutics, Inc. | David Arkowitz | Chief Financial Officer | Oct 30, 2023 | Sale | $1.35 | 4,066 | 5,489 | 175,756 | Oct 31, 2023, 09:39 PM | |
| MCRB | Seres Therapeutics, Inc. | David Arkowitz | Chief Financial Officer | Jun 15, 2022 | Option/RSU Exercise | - | 5,000 | - | 70,492 | Oct 31, 2022, 06:05 PM | |
| MCRB | Seres Therapeutics, Inc. | David Arkowitz | Chief Financial Officer | Jul 05, 2022 | Award/Grant | $3.15 | 63,492 | 200,000 | 65,492 | Jul 06, 2022, 07:23 PM |
- Subscribe
- Premium
- C-Suite
- Insiders
- M&A
- Gurus
- Spinoffs
- Buybacks
- More